Dalam praktiknya, ia mengobati kanker dengan puasa (puasa selang sehari) dan dengan mengurangi makanan padat; ia sendiri dapat bertahan berhari-hari tanpa makanan, hanya dengan jus tebu.
Pernyataan asli
انا ممكن اقعد بالايام ماكلش اصلا ماكلش يعني ماكلش يعني عصير القصب ده وخلاص انت تعرفي تعملي كده اه تعرفي بس انت مش عايزه تعملي كده انت حره برض لا خلي بالك انا السرطان عندي بعالجه بالصيام بالمناسبه صيام يوم اه يوم لا وقلل في الحاجات الصلبه
kata demi kata sesuai sumber. Terjemahan oleh proyek; rumusan bahasa Arab yang menjadi acuan.
Terjemahan
Dalam praktiknya, ia mengobati kanker dengan puasa (puasa selang sehari) dan dengan mengurangi makanan padat; ia sendiri dapat bertahan berhari-hari tanpa makanan, hanya dengan jus tebu.
Asal
- Status sumber
- Transkrip video (kata-katanya sendiri)
- Atribusi
- Elawady (machine transcript)
- Video
- #الدكتور_ضياء_العوضي (Buka sumber)
- Dipublikasikan
- 8 Maret 2024
- Penanda waktu
- 0:00:08 (lokasi dalam trek takarir otomatis YouTube dari video asli; memastikan di mana kata-kata itu muncul, bukan siapa yang berbicara)
- Ketidakpastian atribusi
- Archive transcript (YouTube CC or AI-generated); no timestamps; wording may contain speech-recognition errors; speaker turns are not marked, the excerpt was judged to be Elawady's own speech from context.
- Mekanisme yang diklaim
Not stated in the excerpt.
- Efek kesehatan yang diklaim
Treatment of cancer.
- Populasi yang dimaksud
Cancer patients treated by him.
- Batasan geografis oleh Elawady
none found
Versi sumber yang berbeda
انا السرطان عندي بجه بالصيام بالمناسبه صيام يوم اه يوم لا وقلل في الحاجات الصلبه
With me, cancer - I treat it with fasting, by the way: fasting one day yes, one day no, and reduce solid foods.
- Status sumber
- Transkrip video (kata-katanya sendiri)
- Atribusi
- Elawady (machine transcript)
- Video
- الجزء الخامس من الندوة (Buka sumber)
- Dipublikasikan
- 3 Maret 2024
- Penanda waktu
- 0:00:21 (lokasi dalam trek takarir otomatis YouTube dari video asli; memastikan di mana kata-kata itu muncul, bukan siapa yang berbicara)
- Ketidakpastian atribusi
- Archive transcript (YouTube CC or AI-generated); no timestamps; wording may contain speech-recognition errors; speaker turns are not marked, the excerpt was judged to be Elawady's own speech from context. Same seminar passage in an earlier upload ('part five of the seminar'); 'بجه' is a transcription variant of 'بعالجه' (I treat it).
Penilaian ilmiah
Sebagian besar salah – Bagian-bagian penting dari pernyataan ini tidak didukung oleh bukti atau sangat dilebih-lebihkan.
Tingkat kepastian bukti: rendah – Penelitian lebih lanjut kemungkinan besar akan mengubah penilaian secara bermakna.
1. Apa yang diklaim?
Alternate-day fasting and reducing solid foods are a treatment for cancer.
2. Apa yang terbukti benar?
Fasting during cancer therapy is an active research field. In the randomised phase 2 DIRECT trial (131 women with HER2-negative breast cancer, BMI over 18, no diabetes), a fasting-mimicking diet for a few days around each chemotherapy cycle did not improve the primary endpoint (grade III/IV toxicity) or pathological complete response, but was associated with more radiological responses (OR 3.17) and, per protocol, more near-complete pathological responses (OR 4.11) as secondary findings; adherence was poor and the senior author holds equity in the diet's manufacturer (I-INTA-08). A 2025 systematic review found intermittent fasting during chemotherapy safe and feasible under study conditions (I-INTA-10). A 2026 meta-analysis of three small studies found better tumour shrinkage on scans when patients restricted food around chemotherapy (OR 4.55, 1.64-12.58), but without effects on toxicity or quality of life and without survival data; we could not reproduce its pooled estimate (our recalculation 3.50) (I-SRC-109).
3. Apa yang salah atau dilebih-lebihkan?
These studies tested fasting only as an add-on to chemotherapy, never as a replacement. The systematic review found no demonstrated effect of intermittent fasting on treatment outcomes or toxicity (I-INTA-10). Malnutrition and muscle loss are frequent in cancer patients and worsen outcomes; European guidelines recommend regular malnutrition screening and meeting energy and protein needs (I-INTA-09). Cancer cachexia involves ongoing muscle loss that conventional nutrition cannot fully reverse (I-CAN-06), so repeated fasting and reduced solid food can be harmful. Using alternatives instead of standard treatment is associated with higher mortality (I-CHM-03, I-CHM-04). The ESMO guideline on cancer cachexia recommends nutritional screening and support for all patients on anticancer treatment and at least 25-30 kcal per kg body weight per day (I-SRC-108).
4. Apa yang masih belum jelas?
Whether he combined fasting with standard oncology care for his patients is not stated; no outcomes of his patients are documented. Whether short-term fasting improves survival as an adjunct is unknown.
5. Studi mana yang mendukungnya?
None for fasting as a cancer treatment. I-INTA-08 and I-SRC-109 tested short, supervised dietary restriction only as an add-on to chemotherapy (surrogate endpoints, small studies).
6. Studi mana yang membantahnya?
I-INTA-08 (primary endpoints not improved), I-INTA-10, I-INTA-09, I-SRC-108, I-CAN-06, I-CHM-03, I-CHM-04.
7. Apa yang berlaku untuk Jerman dan Eropa?
ESPEN guidelines (I-INTA-09) are the reference in Europe; fasting is not part of standard cancer treatment.
8. Apa yang diketahui tentang Mesir?
No Egypt-specific data; the same guideline principles apply.
9. Kesimpulan praktis apa yang tepat?
Puasa bukan pengobatan kanker. Periode puasa singkat selama kemoterapi hanya boleh dipertimbangkan dalam studi atau bersama tim onkologi, pada pasien yang tidak mengalami malnutrisi.
Rincian penilaian
- Alasan tingkat kepastian bukti
No clinical study has tested fasting as a stand-alone cancer treatment; trials of short fasting or fasting-mimicking diets as an adjunct to chemotherapy are few and small, with only secondary/per-protocol signals in one phase 2 trial whose primary endpoints were null and an overall systematic review showing no demonstrated effect on outcomes. Harm from malnutrition and from replacing treatment is well documented. Certainty that fasting 'treats' cancer is therefore low, and the claim is rated mostly false rather than false because adjunct fasting is an open research question.
- Kualitas sumber
Elawady's own words in an archive machine transcript (live stream); exact wording may contain recognition errors. Spoken during a seminar (2024).
- Keteralihan ke wilayah lain
High; cancer biology and nutrition guidance are universal.
- Pengecualian individual
Short, supervised fasting periods around chemotherapy are being studied in selected, well-nourished patients without diabetes (I-INTA-08).
- Cakupan wilayah klaim
- umum (biologis/medis)
- Terakhir ditinjau
- 26 Oktober 2026 sementara
Bukti ilmiah secara rinci
Ditafsirkan berlebihan – Ada temuan yang nyata, tetapi klaim ini menarik kesimpulan lebih jauh daripada yang dimungkinkan oleh data (mis. hubungan dianggap sebagai penyebab, data hewan diterapkan pada manusia, efek kecil disajikan sebagai efek besar).
Pertanyaan penelitian: In people with cancer, does alternate-day fasting and reduced solid food intake, used as treatment, improve tumour control or survival compared with standard oncology care with adequate nutrition?
Pertanyaan penelitian secara rinci (PICO)
- Populasi
- Adults with cancer
- Intervensi atau paparan
- Alternate-day fasting / reduced solid food as treatment (alone or with standard care)
- Pembanding
- Standard cancer treatment with nutritional support
- Cakupan geografis
- universal biology
- Luaran
- Overall survival
- Tumour response
- Toxicity
- Malnutrition/cachexia
Hasil studi sebagaimana dilaporkan oleh para penulis. Penilaian kami menyusul di bawah.
Apa yang mendukung klaim ini?
Short fasting alongside cancer treatment
Agrawal K et al.. Cancer Biol Med 2026 · PMID 42444194 · DOI 10.20892/j.issn.2095-3941.2025.0841 Meta-analisisteks lengkap diperiksabaru ditambahkan2026 meta-analysis of dietary restriction during active cancer therapy (letter; full text read).
- Hasil sebenarnya
- Favourable radiological response OR 4.55 (1.64-12.58), 3 studies (169 patients); no significant effect on toxicity or quality of life; survival not studied.
- Kualitas metodologis
- low (3 small studies; pooled OR not reproducible: our MH 3.50)
- Relevansi
- indirect: adjunct to chemotherapy, not stand-alone treatment
- Keterbatasan
- Malnourished patients excluded; surrogate endpoint.
Can short fasting periods help chemotherapy work?
de Groot S et al.. Nature communications 2020 · PMID 32576828 · DOI 10.1038/s41467-020-16138-3 Uji acak terkendaliteks lengkap, penilaian risiko bias terstrukturDIRECT phase 2 RCT of a fasting-mimicking diet around neoadjuvant chemotherapy.
- Hasil sebenarnya
- Primary endpoints (toxicity, pCR) not improved; more radiological responses (OR 3.17) and per-protocol near-complete responses (OR 4.11) as secondary findings.
- Kualitas metodologis
- moderate (RCT, poor adherence)
- Relevansi
- indirect: adjunct only
- Keterbatasan
- Secondary/per-protocol findings; senior author COI.
Apa yang menentang klaim ini?
Refusing standard cancer treatment, not complementary medicine itself, raised the risk of death
Johnson SB et al.. JAMA Oncol 2018 · PMID 30027204 · DOI 10.1001/jamaoncol.2018.2487 Studi kohortabstrak diperiksaNCDB cohort: complementary medicine and refusal of conventional therapy.
- Hasil sebenarnya
- Complementary-medicine users refused more surgery (7.0% vs 0.1%) and chemotherapy (34.1% vs 3.2%); overall death HR 2.08 (1.50-2.90), which became non-significant (HR 1.39, 0.83-2.33) after adjusting for refusal/delay, i.e. the excess risk was mediated by refusing treatment.
- Kualitas metodologis
- low-moderate (observational)
- Relevansi
- direct for replacing treatment
- Keterbatasan
- Confounding; not about fasting specifically.
ESMO guideline on weight loss in cancer
Arends J et al. (ESMO Guidelines Committee). ESMO Open 2021 · PMID 34144781 · DOI 10.1016/j.esmoop.2021.100092 Pedoman / pernyataan sikapabstrak diperiksabaru ditambahkanESMO 2021 cancer cachexia guideline.
- Hasil sebenarnya
- Regular nutritional screening and support for all patients on anticancer therapy; at least 25-30 kcal/kg/day; protein >=1.2 g/kg/day may be needed.
- Kualitas metodologis
- guideline
- Relevansi
- direct for nutritional standard
- Keterbatasan
- Low evidence levels for some points.
Does intermittent fasting help during chemotherapy?
Maes J et al.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2025 · PMID 40970988 · DOI 10.1007/s00520-025-09907-7 Tinjauan sistematisabstrak diperiksa2025 systematic review of intermittent fasting during chemotherapy/targeted therapy.
- Hasil sebenarnya
- Safe and feasible under study conditions; no demonstrated effect on outcomes or toxicity.
- Kualitas metodologis
- moderate
- Relevansi
- direct for adjunct fasting
- Keterbatasan
- Small studies.
Apa kata bukti secara keseluruhan?
Penilaian redaksi berdasarkan studi di atas – bukan hasil studi itu sendiri.
Posisi mana yang lebih didukung?
Fasting is not a cancer treatment; short supervised fasting as an adjunct is an open research question in well-nourished patients.
Mengapa sebagian studi lebih berbobot
Guidelines and outcome data on replacing treatment weigh more than surrogate-endpoint signals from three small adjunct studies whose pooled estimate could not be reproduced.
Apakah hubungan sebab-akibat sudah terbukti? Belum terbukti No trial tests fasting as stand-alone treatment; adjunct benefits are unconfirmed on survival.
Ketidakpastian yang tersisa
Whether short-term fasting improves survival when added to chemotherapy; safety in malnourished patients.
Kesimpulan yang dapat dibenarkan
Alternate-day fasting is not an evidence-based cancer treatment and conflicts with guideline nutrition standards; any fasting during therapy belongs in trials or under the oncology team.
Mengapa studi-studi tampak saling bertentangan?
Apparent conflict between positive adjunct signals (I-SRC-109, I-INTA-08) and guidelines (I-SRC-108) dissolves on inspection: the trials used short, supervised fasting around chemotherapy in non-malnourished patients and measured tumour response, while guidelines address nutrition across the disease course and malnutrition risk.
Apakah ini bergantung pada negara?
- Efek biologis umum
- Universal.
- Kebiasaan makan
- Ramadan-type fasting differs from alternate-day fasting during treatment.
- Asal makanan
- Not applicable.
- Cemaran
- Not applicable.
- Kondisi produksi nasional
- Not applicable.
- Aturan hukum
- Not applicable.
- Data pemantauan sebenarnya
- No Egyptian data.
Perbedaan antarwilayah yang mengubah kesimpulan tidak didukung oleh data yang kuat.
Pemeriksaan ulang statistik
- Recompute per-study ORs from Table 1, Mantel-Haenszel pooled OR, CI symmetry – Per-study ORs 3.75, 2.89, 6.18 (continuity-corrected); MH OR 3.50 vs reported fixed 4.80 and random 4.55; reported CIs log-symmetric. Pooled estimate exceeds two of three study ORs and could not be reproduced. dihitung ulang
Kepastian bukti secara keseluruhan (GRADE, disederhanakan)
- Luaran utama
- Survival/tumour control with fasting as cancer treatment
- Tingkat awal
- tinggi (uji acak)
- Alasan penurunan tingkat
- indirectness: only adjunct studies with surrogate endpoints
- imprecision: very few small studies
- risk of bias: open-label, poor adherence
- Hasil
- sangat rendah
Penilaian sederhana oleh satu penilai, mengikuti pendekatan GRADE; bukan panel GRADE formal. GRADE menilai kumpulan bukti untuk satu luaran, bukan studi individual.
Pedoman klinis dan pernyataan resmi yang diperiksa
- ESMO: Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines (2021) · Publikasi asli
Regular nutritional screening and support for patients on anticancer treatment [V, B]; at least 25-30 kcal/kg/day [V, B]; escalate nutritional interventions when intake is inadequate during anticancer therapy [II, A]. - ESPEN: ESPEN practical guideline: Clinical Nutrition in cancer (2021) · Publikasi asli
Abstract only: 43 recommendations on nutritional and metabolic management of cancer patients, preceded by diagnostics of nutritional status (specific statements not read).
Strategi penelusuran
Penelusuran literatur yang terdokumentasi untuk tinjauan ini (string pencarian dalam sintaksis asli basis data).
| Basis data | Tanggal | Penelusuran | Mencari | Hasil | Disertakan |
|---|---|---|---|---|---|
| Europe PMC | 26 Oktober 2026 | ("short-term fasting" OR "fasting mimicking" OR "intermittent fasting" OR "alternate day fasting") AND cancer AND (randomized OR randomised) AND (chemotherapy OR survival OR response) AND PUB_YEAR:[2020 TO 2026] | bukti pendukung | 1828 | |
| Europe PMC | 26 Oktober 2026 | (fasting OR "caloric restriction") AND cancer patients AND (meta-analysis OR "systematic review") AND (survival OR toxicity OR "quality of life") AND PUB_YEAR:[2022 TO 2026] | kedua arah | 13348 | |
| PubMed | 26 Oktober 2026 | ESPEN practical guideline clinical nutrition in cancer | pedoman | 40 | |
| PubMed | 26 Oktober 2026 | cancer cachexia ESMO clinical practice guideline 2021 | pedoman | 1 | |
| PubMed | 26 Oktober 2026 | (alternative medicine OR complementary medicine OR "refusal of conventional") AND cancer AND survival AND (cohort OR "National Cancer Database") | bukti yang menentang | 2446 |
Pertanyaan terbuka
Survival effect of supervised fasting as an adjunct; reproduction of the pooled OR.
Seberapa mendalam ini diperiksa?
8 studi terkait: 2 diperiksa dalam teks lengkap (1 di antaranya dengan penilaian risiko bias terstruktur), 6 berdasarkan abstrak, 0 hanya secara bibliografis. Belum ada penilaian formal oleh dua penilai independen dan belum ada tinjauan pakar manusia yang independen.
Tinjauan ilmiah terakhir: 26 Oktober 2026
Riwayat penilaian
- 25 Oktober 2026 · Fase 1 · Penilaian awal: Sebagian besar salah (rendah)
- 26 Oktober 2026 · Fase 4 (tinjauan bukti sistematis) · Diperiksa ulang dengan bukti yang diperluas; penilaian tidak berubah: Sebagian besar salah (rendah)
New 2026 meta-analysis adds a weak, partly irreproducible adjunct signal and the ESMO guideline confirms nutritional standards; verdict and low certainty unchanged.
Sumber baru: I-SRC-108 I-SRC-109
Dalam bahasa sederhana
Dr. Elawady mengatakan bahwa ia mengobati kanker dengan puasa selang sehari dan dengan makan lebih sedikit makanan padat. Beberapa studi kecil sedang menguji periode puasa singkat bersamaan dengan kemoterapi, dan satu uji pada kanker payudara menunjukkan respons tumor yang lebih baik. Namun, tidak ada studi yang menunjukkan bahwa puasa saja dapat mengobati kanker, dan sebuah tinjauan atas sembilan studi tidak menemukan efek yang terbukti terhadap hasil pengobatan. Banyak pasien kanker kehilangan berat badan dan otot, yang memperburuk hasil pengobatan, sehingga dokter berupaya memastikan mereka makan dengan cukup.
Studi tentang klaim ini
Studi yang mendukung klaim (0)
Tidak ada studi dalam kelompok ini.
Studi yang membantah atau membatasi klaim (7)
-
Does intermittent fasting help during chemotherapy?
Maes J et al.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2025 · PMID 40970988 · DOI 10.1007/s00520-025-09907-7Tinjauan sistematispemeriksaan silang independenabstrak diperiksa★ studi kunciNine small studies found fasting feasible and safe under supervision but showed no proven effect on treatment results or side effects.
No demonstrated effect on treatment outcomes.
Apakah studi ini mendukung klaim spesifik tersebut? Tidak · Kualitas metodologis: sedang · Tingkat kepastian bukti: lihat penilaian keseluruhan atas klaim
Publikasi asli · Rincian ilmiah
Penjelasan studi secara sederhana
- Apa yang ingin diketahui para peneliti?
Intermittent fasting during cancer therapy
- Bagaimana studi ini dilakukan?
Systematic review
- Berapa banyak orang, hewan, atau sampel yang diteliti?
9 studies, 354 patients
- Apa yang sebenarnya ditemukan?
Safe and feasible; no demonstrated effect on outcomes
- Seberapa besar efek yang teramati?
Not pooled
- Apa arti hasilnya dalam kehidupan sehari-hari?
Fasting is not a proven cancer treatment
- Apa keterbatasan studi ini?
Few small studies
- Apa yang dikatakannya tentang klaim spesifik Elawady?
Contradicts 'treating cancer with fasting'
- Apakah hasilnya berlaku untuk Jerman dan Eropa?
High
- Apa yang secara tegas tidak dapat disimpulkan dari studi ini?
Effects of fasting without standard treatment (not studied)
-
What should cancer patients eat?
Arends J et al.. Clinical nutrition (Edinburgh, Scotland) 2017 · PMID 27637832 · DOI 10.1016/j.clnu.2016.07.015Pedoman / pernyataan sikappemeriksaan silang independenabstrak diperiksa★ studi kunciEuropean guidelines say cancer patients should be screened for malnutrition and should get enough energy and protein.
Guideline aims to meet energy needs and prevent malnutrition in cancer patients.
Apakah studi ini mendukung klaim spesifik tersebut? Tidak · Kualitas metodologis: tinggi · Tingkat kepastian bukti: lihat penilaian keseluruhan atas klaim
Publikasi asli · Rincian ilmiah
Penjelasan studi secara sederhana
- Apa yang ingin diketahui para peneliti?
Nutrition in cancer
- Bagaimana studi ini dilakukan?
Clinical guideline (GRADE)
- Berapa banyak orang, hewan, atau sampel yang diteliti?
Adult cancer patients
- Apa yang sebenarnya ditemukan?
Malnutrition worsens outcomes; energy needs should be met
- Seberapa besar efek yang teramati?
Not applicable
- Apa arti hasilnya dalam kehidupan sehari-hari?
Deliberately eating less is risky for many cancer patients
- Apa keterbatasan studi ini?
Abstract only
- Apa yang dikatakannya tentang klaim spesifik Elawady?
Contradicts fasting as a general cancer treatment
- Apakah hasilnya berlaku untuk Jerman dan Eropa?
High
- Apa yang secara tegas tidak dapat disimpulkan dari studi ini?
Effects of short supervised fasting
-
Cancer wasting is caused by the cancer itself
Fearon K et al.. Lancet Oncol 2011 · PMID 21296615 · DOI 10.1016/S1470-2045(10)70218-7Pedoman / pernyataan sikappemeriksaan silang independenabstrak diperiksaExperts define cachexia as muscle loss driven by the tumour's effects on metabolism and appetite, not fully reversible by food.
Apakah studi ini mendukung klaim spesifik tersebut? Tidak · Kualitas metodologis: sedang · Tingkat kepastian bukti: lihat penilaian keseluruhan atas klaim
Publikasi asli · Rincian ilmiah
Penjelasan studi secara sederhana
- Apa yang ingin diketahui para peneliti?
Define cachexia.
- Bagaimana studi ini dilakukan?
Delphi consensus.
- Berapa banyak orang, hewan, atau sampel yang diteliti?
Experts.
- Apa yang sebenarnya ditemukan?
Definition.
- Apa arti hasilnya dalam kehidupan sehari-hari?
Weight loss in cancer needs medical attention.
- Apa keterbatasan studi ini?
Consensus.
- Apa yang dikatakannya tentang klaim spesifik Elawady?
Contradicts 'not dying of cancer'.
- Apakah hasilnya berlaku untuk Jerman dan Eropa?
High.
-
Patients who used only alternative medicine for curable cancer died more often
Johnson SB et al.. J Natl Cancer Inst 2018 · PMID 28922780 · DOI 10.1093/jnci/djx145Studi kohortpemeriksaan silang independenabstrak diperiksa★ studi kunciRisk of death was 2.5 times higher overall and 5.7 times higher for breast cancer.
Apakah studi ini mendukung klaim spesifik tersebut? Tidak · Kualitas metodologis: sedang · Tingkat kepastian bukti: lihat penilaian keseluruhan atas klaim
Publikasi asli · Rincian ilmiah
Penjelasan studi secara sederhana
- Apa yang ingin diketahui para peneliti?
Compare AM-only vs conventional treatment.
- Bagaimana studi ini dilakukan?
Matched registry cohort.
- Berapa banyak orang, hewan, atau sampel yang diteliti?
840 matched patients.
- Apa yang sebenarnya ditemukan?
HR 2.50 for death.
- Seberapa besar efek yang teramati?
HR 5.68 breast cancer.
- Apa arti hasilnya dalam kehidupan sehari-hari?
Replacing cancer treatment with alternatives is dangerous.
- Apa keterbatasan studi ini?
Observational.
- Apa yang dikatakannya tentang klaim spesifik Elawady?
Contradicts refusing therapy.
- Apakah hasilnya berlaku untuk Jerman dan Eropa?
Moderate.
- Apa yang secara tegas tidak dapat disimpulkan dari studi ini?
Effects of complementary approaches used alongside treatment.
-
Refusing standard cancer treatment, not complementary medicine itself, raised the risk of death
Johnson SB et al.. JAMA Oncol 2018 · PMID 30027204 · DOI 10.1001/jamaoncol.2018.2487Studi kohortpemeriksaan silang independenabstrak diperiksa★ studi kunciUsers of complementary medicine refused chemotherapy or radiotherapy far more often and had about twice the risk of death.
Apakah studi ini mendukung klaim spesifik tersebut? Tidak · Kualitas metodologis: sedang · Tingkat kepastian bukti: lihat penilaian keseluruhan atas klaim
Publikasi asli · Rincian ilmiah
Penjelasan studi secara sederhana
- Apa yang ingin diketahui para peneliti?
Study CM and survival.
- Bagaimana studi ini dilakukan?
Registry cohort.
- Berapa banyak orang, hewan, atau sampel yang diteliti?
258 vs 1,032.
- Apa yang sebenarnya ditemukan?
HR 2.08; explained by refusal.
- Seberapa besar efek yang teramati?
5-y OS 82.2% vs 86.6%.
- Apa arti hasilnya dalam kehidupan sehari-hari?
Diet or other approaches alongside treatment are not the problem; replacing treatment is.
- Apa keterbatasan studi ini?
Observational.
- Apa yang dikatakannya tentang klaim spesifik Elawady?
Contradicts refusal advice.
- Apakah hasilnya berlaku untuk Jerman dan Eropa?
Moderate.
- Apa yang secara tegas tidak dapat disimpulkan dari studi ini?
Causal effect of any single CM.
-
Can short fasting periods help chemotherapy work?
de Groot S et al.. Nature communications 2020 · PMID 32576828 · DOI 10.1038/s41467-020-16138-3Uji acak terkendalipemeriksaan silang independenteks lengkap, penilaian risiko bias terstruktur★ studi kunciIn 131 women with breast cancer, a fasting-mimicking diet around chemotherapy did not reduce severe side effects or increase complete tumour disappearance (the main outcomes); tumour shrinkage on imaging was more frequent, but this was a secondary result.
Fasting-mimicking diet showed better tumour response as an adjunct to chemotherapy, not as stand-alone treatment.
Apakah studi ini mendukung klaim spesifik tersebut? Sebagian · Kualitas metodologis: sedang · Tingkat kepastian bukti: lihat penilaian keseluruhan atas klaim
Publikasi asli · Rincian ilmiah
Penjelasan studi secara sederhana
- Apa yang ingin diketahui para peneliti?
Fasting-mimicking diet with chemotherapy
- Bagaimana studi ini dilakukan?
Randomised phase 2 trial
- Berapa banyak orang, hewan, atau sampel yang diteliti?
131 women, HER2-negative breast cancer
- Apa yang sebenarnya ditemukan?
More tumour responses with FMD; no toxicity difference
- Seberapa besar efek yang teramati?
pCR 10.8% vs 12.7% (no difference); radiological response OR 3.17 (1.06-9.45); pathological response OR 4.11 (per-protocol)
- Apa arti hasilnya dalam kehidupan sehari-hari?
Fasting may become a supportive tool during chemotherapy, under supervision
- Apa keterbatasan studi ini?
Phase 2; main outcomes not improved; benefit only in secondary and per-protocol analyses; poor adherence; lead author holds equity in the diet's manufacturer
- Apa yang dikatakannya tentang klaim spesifik Elawady?
Supports research on fasting as an add-on, not fasting instead of treatment
- Apakah hasilnya berlaku untuk Jerman dan Eropa?
High
- Apa yang secara tegas tidak dapat disimpulkan dari studi ini?
That fasting alone treats cancer
-
ESMO guideline on weight loss in cancer
Arends J et al. (ESMO Guidelines Committee). ESMO Open 2021 · PMID 34144781 · DOI 10.1016/j.esmoop.2021.100092Pedoman / pernyataan sikappemeriksaan silang independenabstrak diperiksaCancer patients on treatment should be screened for malnutrition and get at least 25-30 kcal per kg body weight per day.
Guideline requires at least 25-30 kcal/kg/day and adequate protein during cancer therapy.
Apakah studi ini mendukung klaim spesifik tersebut? Tidak · Kualitas metodologis: sedang · Tingkat kepastian bukti: lihat penilaian keseluruhan atas klaim
Publikasi asli · Rincian ilmiah
Penjelasan studi secara sederhana
- Apa yang ingin diketahui para peneliti?
Guide cachexia care
- Bagaimana studi ini dilakukan?
Guideline
- Berapa banyak orang, hewan, atau sampel yang diteliti?
not applicable
- Apa yang sebenarnya ditemukan?
Screen and feed adequately; escalate nutrition when intake is low
- Seberapa besar efek yang teramati?
not applicable
- Apa arti hasilnya dalam kehidupan sehari-hari?
Cancer patients need enough food, not fasting regimes
- Apa keterbatasan studi ini?
Low evidence levels for some points
- Apa yang dikatakannya tentang klaim spesifik Elawady?
Contradicts fasting as treatment
- Apakah hasilnya berlaku untuk Jerman dan Eropa?
High
Tidak ada studi dalam kelompok ini yang ditandai sebagai studi kunci.
Studi dengan hasil campuran atau tidak jelas (1)
-
Short fasting alongside cancer treatment
Agrawal K et al.. Cancer Biol Med 2026 · PMID 42444194 · DOI 10.20892/j.issn.2095-3941.2025.0841Meta-analisispemeriksaan silang independenteks lengkap diperiksa★ studi kunciIn three small studies, patients who restricted food during chemotherapy had better tumour shrinkage on scans; survival was not studied.
Adjunct restriction during chemotherapy associated with better radiological response in 3 small studies; not a replacement for treatment.
Apakah studi ini mendukung klaim spesifik tersebut? Sebagian · Kualitas metodologis: rendah · Tingkat kepastian bukti: lihat penilaian keseluruhan atas klaim
Publikasi asli · Rincian ilmiah
Penjelasan studi secara sederhana
- Apa yang ingin diketahui para peneliti?
Pool studies of dietary restriction during cancer therapy
- Bagaimana studi ini dilakukan?
Systematic review and meta-analysis
- Berapa banyak orang, hewan, atau sampel yang diteliti?
3 studies (169 patients) for response
- Apa yang sebenarnya ditemukan?
Better radiological response; no clear change in toxicity or quality of life
- Seberapa besar efek yang teramati?
OR 4.55 (1.64-12.58), not reproducible (our MH 3.50)
- Apa arti hasilnya dalam kehidupan sehari-hari?
Fasting is being studied only as an add-on to treatment
- Apa keterbatasan studi ini?
Very small evidence base; reporting problems
- Apa yang dikatakannya tentang klaim spesifik Elawady?
Does not support fasting instead of treatment
- Apakah hasilnya berlaku untuk Jerman dan Eropa?
Research setting
- Apa yang secara tegas tidak dapat disimpulkan dari studi ini?
Whether fasting prolongs life or replaces treatment
Tidak ada studi dalam kelompok ini yang ditandai sebagai studi kunci.
Konteks wilayah
Jerman / UE
ESPEN guidelines (I-INTA-09) are the reference in Europe; fasting is not part of standard cancer treatment.
Mesir
No Egypt-specific data; the same guideline principles apply.
Apa yang berlaku di negara saya?
Penilaian ilmiah umum
Sebagian besar salah Puasa mungkin dapat menjadi alat pendukung selama kemoterapi, tetapi bukan pengobatan kanker dan dapat berbahaya bila menyebabkan malnutrisi atau menggantikan terapi.
Pernyataan ini menyangkut hubungan biologis atau medis. Penilaian ilmiah di atas berlaku tanpa bergantung pada negara; data pangan khusus negara tidak mengubahnya.
Referensi
- Impact of intermittent fasting on patients with cancer undergoing chemotherapy and/or targeted therapies: a systematic review of the literature.. Maes J et al.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2025 · PMID 40970988 · DOI 10.1007/s00520-025-09907-7
- ESPEN guidelines on nutrition in cancer patients.. Arends J et al.. Clinical nutrition (Edinburgh, Scotland) 2017 · PMID 27637832 · DOI 10.1016/j.clnu.2016.07.015
- Definition and classification of cancer cachexia: an international consensus.. Fearon K et al.. Lancet Oncol 2011 · PMID 21296615 · DOI 10.1016/S1470-2045(10)70218-7
- Use of Alternative Medicine for Cancer and Its Impact on Survival.. Johnson SB et al.. J Natl Cancer Inst 2018 · PMID 28922780 · DOI 10.1093/jnci/djx145
- Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers.. Johnson SB et al.. JAMA Oncol 2018 · PMID 30027204 · DOI 10.1001/jamaoncol.2018.2487
- Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.. de Groot S et al.. Nature communications 2020 · PMID 32576828 · DOI 10.1038/s41467-020-16138-3
- Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆.. Arends J et al. (ESMO Guidelines Committee). ESMO Open 2021 · PMID 34144781 · DOI 10.1016/j.esmoop.2021.100092
- Dietary restriction during active cancer therapy is associated with improved treatment response: a systematic review and meta-analysis.. Agrawal K et al.. Cancer Biol Med 2026 · PMID 42444194 · DOI 10.20892/j.issn.2095-3941.2025.0841